Ginkgo Bioworks Inc.
(DNA)
undefined
undefined%
At close: undefined
11.36
-1.26%
After-hours Jan 03, 2025, 05:47 PM EST
Company Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming.
Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum.
The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals.
Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform.
Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Ginkgo Bioworks Inc.
| Country | United States |
| IPO Date | Apr 19, 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1,218 |
| CEO | Dr. Jason Kelly Ph.D. |
Contact Details
Address: 27 Drydock Avenue Boston, Massachusetts United States | |
| Website | https://www.ginkgobioworks.com |
Stock Details
| Ticker Symbol | DNA |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001830214 |
| CUSIP Number | 37611X100 |
| ISIN Number | US37611X1000 |
| Employer ID | 87-2652913 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jason Kelly Ph.D. | Founder, Chief Executive Officer & Director |
| Bartholomew Canton Ph.D. | Founder, Chief Technology Officer & Secretary |
| Dr. Reshma P. Shetty | Founder, President, Chief Operating Officer & Director |
| Mark E. Dmytruk | Chief Financial Officer |
| Anna Marie Wagner M.B.A. | Senior Vice President of Corporate Development |
| Austin Che Ph.D. | Founder, Head of Strategy & Treasurer |
| Karen Tepichin | General Counsel & Secretary |
| Samantha Sutton | Head of People |
| Steven P. Coen CPA | Chief Accounting Officer |
| Thomas Knight Jr. | Founder |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 13, 2024 | 4 | Filing |
| Dec 05, 2024 | 4 | Filing |
| Dec 05, 2024 | 4 | Filing |
| Nov 22, 2024 | 4 | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 8-K | Current Report |
| Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 08, 2024 | 4 | Filing |
| Nov 08, 2024 | 3 | Filing |